Trades on 4 secondary markets

BigHat Biosciences

BigHat Biosciences is a biotechnology company that pairs machine learning with a high-throughput, fully integrated wet lab to design next-generation antibody-based therapeutics. Its platform closes the loop between in-silico antibody design and in-house synthesis and characterization, generating pro

minimal 8.6 / 100 0 APIs View provider profile →

Company Biotechnology Antibody Design Machine Learning Drug Discovery Therapeutics

BigHat Biosciences is an API provider whose private shares are listed on 4 secondary markets: Forge Global, Hiive, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.